ADVFN US – Market Content Editor

  • General Mills Stock Drops to 52-Week Low of $50.13 Amid Industry Headwinds

    General Mills Stock Drops to 52-Week Low of $50.13 Amid Industry Headwinds

    General Mills (NYSE:GIS) shares slid to a 52-week low of $50.13, underscoring the hurdles the company has encountered over the past year. The stock currently trades with a P/E ratio of 12.4 and offers a dividend yield of 4.8%, maintaining a remarkable streak of 55 consecutive years of dividend payments. Despite this, the share price…

  • AutoNation Stock Climbs to Record $214.09 Amid Strong Growth Momentum

    AutoNation Stock Climbs to Record $214.09 Amid Strong Growth Momentum

    AutoNation Inc. (NYSE:AN) reached a new all-time high, with shares hitting $214.09, highlighting the company’s solid market performance. Over the past year, the stock has delivered a notable 32.73% return, supported by a market cap of $8.04 billion and a price-to-earnings ratio of 12.4x. The automotive retailer’s upward trajectory reflects robust consumer demand and successful…

  • ZenaTech Shares Jump 3.9% After Breakthrough in Quantum Computing Prototype

    ZenaTech Shares Jump 3.9% After Breakthrough in Quantum Computing Prototype

    ZenaTech Inc. (NASDAQ:ZENA) saw its stock climb 3.9% following the announcement of a successful development of a quantum computing prototype designed to boost its AI drone technology. The company introduced a new system that enables rapid processing and analysis of extensive datasets collected by AI drone sensors in real-time. The prototype was trialed with weather…

  • Painreform Shares Drop 11% After Revealing Strategic Stake in LayerBio

    Painreform Shares Drop 11% After Revealing Strategic Stake in LayerBio

    Painreform Ltd (NASDAQ:PRFX) shares declined 11% following the company’s announcement of a strategic investment deal with LayerBio Inc., a private biotech firm based in Boston. Under the terms, Painreform will acquire a majority equity interest in LayerBio along with a controlling position on its board, in exchange for up to $3 million in funding tied…

  • BIT Mining Stock Rockets 160% After Strategic Move into Solana Ecosystem

    BIT Mining Stock Rockets 160% After Strategic Move into Solana Ecosystem

    BIT Mining Limited (NYSE:BTCM) shares surged by 160% following the company’s announcement of a major strategic pivot to expand its presence within the Solana blockchain network. The firm outlined plans to establish a significant SOL token treasury, aiming to raise between $200 million and $300 million in stages, contingent on market conditions, to bolster its…

  • XCF Global Shares Surge After Announcing $1 Billion Expansion in SAF Production

    XCF Global Shares Surge After Announcing $1 Billion Expansion in SAF Production

    XCF Global Inc (NASDAQ:SAFX) saw its stock price soar by 130% following the company’s announcement of a nearly $1 billion investment to establish a network of Synthetic Aviation Fuel (SAF) production facilities both in the U.S. and abroad. This major funding will boost XCF’s output capacity to around 160 million gallons annually by the end…

  • Allurion Technologies Shares Gain Following Canadian Distribution Deal

    Allurion Technologies Shares Gain Following Canadian Distribution Deal

    Shares of Allurion Technologies Inc (NYSE:ALUR) climbed 2.9% after the company announced a strategic distribution partnership with Canadian medical device firm Minogue Medical Inc., which specializes in bariatric and obesity treatment solutions. This collaboration taps into Minogue Medical’s four decades of experience in the Canadian healthcare market and its broad network of dietitians, bariatric surgeons,…

  • PDS Biotechnology Shares Climb Following Trial Expansion Milestone

    PDS Biotechnology Shares Climb Following Trial Expansion Milestone

    Shares of PDS Biotechnology Corp (NASDAQ:PDSB) increased 3.8% after the company revealed its clinical trial for metastatic colorectal cancer has met key benchmarks, allowing progression to Stage 2. The late-stage immunotherapy developer confirmed that Stage 1 patient enrollment is complete for the trial testing the PDS01ADC therapy administered alongside floxuridine. Conducted by the National Cancer…

  • Cognition Therapeutics Shares Jump 75% After FDA Discussion on Alzheimer’s Treatment

    Cognition Therapeutics Shares Jump 75% After FDA Discussion on Alzheimer’s Treatment

    Cognition Therapeutics Inc. (NASDAQ:CGTX) saw its stock climb sharply by 75% following a productive end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) concerning its Alzheimer’s drug candidate. On July 9, the clinical-stage biotech company engaged with FDA representatives to review the outcomes of its Phase 2 trial for zervimesine (CT1812) and to…

  • Tonix Pharmaceuticals Shares Climb on Encouraging TNX-801 Vaccine Results

    Tonix Pharmaceuticals Shares Climb on Encouraging TNX-801 Vaccine Results

    Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw its stock rise 2% after unveiling new preclinical findings for its TNX-801 vaccine candidate at the 2025 Vaccine Congress in Vienna. The biopharma company highlighted that its recombinant horsepox-based vaccine demonstrates promising potential to provide long-lasting immunity while being significantly more attenuated than earlier orthopoxvirus vaccines. Notably, the data…